Signs and Symptoms, Digestive
Welcome,         Profile    Billing    Logout  
 93 Companies   118 Products   118 Products   88 Mechanisms of Action   3 Trials   1622 News 


«12345678910111213...3233»
  • ||||||||||  Trial initiation date:  LACTINEDAP: Limited Abdominal CT in ED Patients With Abdominal Pain (clinicaltrials.gov) -  Mar 16, 2016   
    P=N/A,  N=1000, Not yet recruiting, 
    Completed --> Suspended | Trial primary completion date: Mar 2013 --> May 2014 Initiation date: May 2015 --> May 2016
  • ||||||||||  Enrollment closed, Enrollment change, Trial primary completion date:  The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa (clinicaltrials.gov) -  Mar 1, 2016   
    P2,  N=23, Active, not recruiting, 
    Recruiting --> Completed | N=56 --> 27 Recruiting --> Active, not recruiting | N=30 --> 23 | Trial primary completion date: Mar 2016 --> Sep 2016
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Pelvic Examination in Pregnancy (clinicaltrials.gov) -  Feb 18, 2016   
    P=N/A,  N=270, Completed, 
    Active, not recruiting --> Completed | N=106 --> 54 | Trial primary completion date: Dec 2016 --> Dec 2015 Recruiting --> Completed | N=800 --> 270 | Trial primary completion date: Jan 2013 --> Jan 2016
  • ||||||||||  Trial completion, Trial primary completion date:  Body Image Therapy in Anorexia Nervosa (clinicaltrials.gov) -  Feb 13, 2016   
    P=N/A,  N=100, Completed, 
    Recruiting --> Completed | N=800 --> 270 | Trial primary completion date: Jan 2013 --> Jan 2016 Recruiting --> Completed | Trial primary completion date: Oct 2015 --> Feb 2016
  • ||||||||||  Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
    Trial completion, Trial primary completion date:  Trial of Linaclotide in Patients With Chronic Idiopathic Constipation (clinicaltrials.gov) -  Feb 12, 2016   
    P3,  N=1223, Completed, 
    Recruiting --> Completed | Trial primary completion date: Oct 2015 --> Feb 2016 Recruiting --> Completed | Trial primary completion date: Jul 2016 --> Aug 2015
  • ||||||||||  omeprazole / Generic mfg.
    Trial suspension:  Use of Maytenus Ilicifolia in the Treatment of Dyspepsia (clinicaltrials.gov) -  Jan 28, 2016   
    P2,  N=140, Suspended, 
    N=16 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Jan 2014 --> Oct 2015 Recruiting --> Suspended
  • ||||||||||  Trial primary completion date, Surgery, Metastases:  Decreasing Narcotics in Advanced Pelvic Surgery (clinicaltrials.gov) -  Jan 26, 2016   
    P4,  N=136, Recruiting, 
    N=20 --> 0 | Terminated --> Withdrawn Trial primary completion date: Jan 2016 --> May 2016
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Dose-Responsive Effect of Polydextrose on Whole Gut Transit Time (clinicaltrials.gov) -  Jan 22, 2016   
    P=N/A,  N=59, Terminated, 
    Active, not recruiting --> Terminated; low incidence N=184 --> 59 | Active, not recruiting --> Terminated | Trial primary completion date: Jan 2015 --> Nov 2013; Slow recruitment
  • ||||||||||  Emend intravenous (fosaprepitant) / Merck (MSD), Ono Pharma
    Trial termination, Metastases:  Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma (clinicaltrials.gov) -  Jan 21, 2016   
    P2b,  N=12, Terminated, 
    N=184 --> 59 | Active, not recruiting --> Terminated | Trial primary completion date: Jan 2015 --> Nov 2013; Slow recruitment N=22 --> 12 | Recruiting --> Terminated | Trial primary completion date: Sep 2015 --> Sep 2016 | Recruiting --> Terminated; Enrollment issues
  • ||||||||||  dexamethasone injection / Generic mfg.
    Trial primary completion date:  Dexamethasone for Post-cesarean Delivery Pain (clinicaltrials.gov) -  Jan 21, 2016   
    P4,  N=104, Recruiting, 
    N=22 --> 12 | Recruiting --> Terminated | Trial primary completion date: Sep 2015 --> Sep 2016 | Recruiting --> Terminated; Enrollment issues Trial primary completion date: Dec 2015 --> Dec 2016
  • ||||||||||  Acofide (acotiamide) / Zeria, Astellas
    Enrollment closed, P3 data, Enrollment change, Trial primary completion date:  Phase III, Long-term, Open-label Safety Study of Z-338 (clinicaltrials.gov) -  Jan 19, 2016   
    P3,  N=207, Active, not recruiting, 
    Recruiting --> Active, not recruiting | N=70 --> 21 Recruiting --> Active, not recruiting | N=350 --> 207 | Trial primary completion date: Jan 2016 --> Feb 2017
  • ||||||||||  Trial primary completion date:  Neural Links Between OCD and Anorexia (clinicaltrials.gov) -  Jan 18, 2016   
    P=N/A,  N=45, Recruiting, 
    Recruiting --> Active, not recruiting | N=350 --> 207 | Trial primary completion date: Jan 2016 --> Feb 2017 Trial primary completion date: Jan 2016 --> Aug 2016
  • ||||||||||  fluoxetine / Generic mfg.
    Trial completion, Enrollment change:  PET Imaging Study of Recovered Anorexics (clinicaltrials.gov) -  Jan 16, 2016   
    P=N/A,  N=23, Completed, 
    N=20 --> 0 Active, not recruiting --> Completed | N=120 --> 23
  • ||||||||||  Trial initiation date, Trial primary completion date:  Recurrent Abdominal Pain in Children (clinicaltrials.gov) -  Jan 7, 2016   
    P2,  N=168, Completed, 
    Recruiting --> Completed | N=240 --> 165 | Trial primary completion date: Jun 2014 --> Jul 2015 Initiation date: Jul 2007 --> Jan 2009 | Trial primary completion date: Dec 2013 --> Mar 2014
  • ||||||||||  Barhemsys (intravenous amisulpride) / Acacia Pharma
    Trial completion:  Phase IIIb Study of APD421 in Combination as PONV Prophylaxis (clinicaltrials.gov) -  Jan 5, 2016   
    P3,  N=1204, Completed, 
    Initiation date: Jul 2007 --> Jan 2009 | Trial primary completion date: Dec 2013 --> Mar 2014 Recruiting --> Completed
  • ||||||||||  Trial primary completion date:  Lcr35 for Children With Functional Constipation (clinicaltrials.gov) -  Dec 30, 2015   
    P4,  N=94, Recruiting, 
    Recruiting --> Active, not recruiting Trial primary completion date: Dec 2015 --> Jun 2016
  • ||||||||||  Trial primary completion date:  Adaptive Family Treatment for Adolescent Anorexia Nervosa (clinicaltrials.gov) -  Dec 15, 2015   
    P=N/A,  N=90, Active, not recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Sep 2015 --> Dec 2015
  • ||||||||||  Carafate (sucralfate) / AbbVie
    Enrollment change, Trial withdrawal, Trial primary completion date:  CE_NERD: Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD) (clinicaltrials.gov) -  Dec 10, 2015   
    P=N/A,  N=0, Withdrawn, 
    Active, not recruiting --> Completed N=120 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jan 2015 --> Dec 2015
  • ||||||||||  Enrollment closed:  TreCogAM: Cognitive Remediation Therapy in Anorexia Nervosa (clinicaltrials.gov) -  Dec 10, 2015   
    P=N/A,  N=120, Active, not recruiting, 
    N=120 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jan 2015 --> Dec 2015 Recruiting --> Active, not recruiting
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Internet Intervention for Adolescents With Chronic Pain (clinicaltrials.gov) -  Dec 5, 2015   
    P2,  N=273, Completed, 
    Trial primary completion date: Oct 2015 --> Oct 2016 Active, not recruiting --> Completed | N=600 --> 273 | Trial primary completion date: Aug 2015 --> Nov 2015
  • ||||||||||  Xifaxan (rifaximin) / Alfa Wassermann, Bausch Health, Norgine, ASKA Pharma
    Trial completion, Trial primary completion date:  Rifaximin for Functional Dyspepsia (clinicaltrials.gov) -  Dec 5, 2015   
    P2/3,  N=95, Completed, 
    Active, not recruiting --> Completed | N=600 --> 273 | Trial primary completion date: Aug 2015 --> Nov 2015 Recruiting --> Completed | Trial primary completion date: Sep 2015 --> May 2015
  • ||||||||||  Trial completion, Trial primary completion date:  Virtual Reality Based Cue-exposure Treatment for Bulimia Nervosa (clinicaltrials.gov) -  Dec 4, 2015   
    P=N/A,  N=60, Completed, 
    Trial primary completion date: Apr 2016 --> Apr 2017 Not yet recruiting --> Completed | Trial primary completion date: Jul 2015 --> Oct 2015
  • ||||||||||  Cesamet (nabilone) / Bausch Health, Viatris
    Trial completion, Trial primary completion date, Surgery:  Study of Prevention of Postoperative Nausea and Vomiting Using Cesamet (clinicaltrials.gov) -  Dec 4, 2015   
    P2,  N=331, Completed, 
    Not yet recruiting --> Completed | Trial primary completion date: Jul 2015 --> Oct 2015 Recruiting --> Completed | Trial primary completion date: Apr 2016 --> Jan 2015
  • ||||||||||  Trial completion:  Emergency Department Ultrasound in Renal Colic (clinicaltrials.gov) -  Nov 28, 2015   
    P=N/A,  N=414, Completed, 
    Trial primary completion date: Oct 2015 --> Aug 2016 Active, not recruiting --> Completed